Lecture time

Lecture location

Conference Room 302, Building 1, Jinfeng Laboratory

Maria Dorobantu , Fellow of the European Society of Cardiology (FESC), Fellow of the American College of Cardiology (FACC). Emeritus professor at the "Carol Davila" University of Medicine and Pharmacy in Romania, expert in cardiology and internal medicine. He is a corresponding member of the Romanian Academy of Sciences, an academician of the Romanian Academy of Medical Sciences, a foreign corresponding member of the French National Academy of Medical Sciences, and an academician of the European Academy of Sciences. He served as a visiting professor in the Department of Cardiovascular Diseases at Northwestern University Feinberg School of Medicine in the United States and received an honorary doctorate from Vasily Gordish University of the West in Romania. He has long been engaged in clinical and basic research on cardiovascular diseases and has achieved important results in the fields of hypertension, coronary heart disease, heart failure and early intervention and prevention of cardiovascular diseases. 。

Myocardial regeneration and cardiac function repair after myocardial infarction are major clinical problems. Although reperfusion therapy effectively reduces mortality in the acute phase of myocardial infarction, a large number of patients will still progress to heart failure in the long term. Stem cell therapy is a highly potential myocardial regeneration treatment strategy. Although some progress has been made after years of research and exploration, there are still many controversies and problems such as unclear mechanism of action and unstable clinical efficacy. This lecture will systematically review the classic literature and cutting-edge research progress in the field of stem cell treatment of myocardial infarction, explain in detail the mechanisms of action of different types of stem cells, transplantation options and the current status of clinical translation and application. At the same time, it will focus on sharing the original research results and practical experience of the lecturer team who have been deeply involved in this field for many years.

Liu Guoqing , postdoctoral fellow at the University of South Florida, director of the Cord Blood Stem Cell Bank at the University of South Florida, member of the American Association of Blood Banks (AABB), member of the European Society of Hematology, member of the American Society of Hematology, member of the New York Association of Scientists, and member of the American Academy of Allergy and Immunology； He has been engaged in stem cell scientific research for 36 years and has been engaged in stem cell bank management for 30 years, with rich experience.

The stem cell research center will introduce the world's first research work using umbilical cord hematopoietic stem cells and clinical examples of using cord blood hematopoietic stem cells and cord blood mesenchymal stem cells to treat diseases. Conduct a comprehensive and in-depth analysis from aspects such as stem cell treatment methods, carcinogenic risks, and administration methods.